vaccines
Blood Test From Stanford-led Team Could Predict Vaccine Durability
Bone marrow cells called megakaryocytes produce platelets with transcriptional programs that enhance antibody response times to several vaccines.
Personalis Nabs $50M Investment From Merck, Extends Collaboration with Moderna
The company extended its collaboration to further advance an investigational personalized vaccine therapy under development by Merck and Moderna.
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.
The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals.
Finnish Diagnostic Firm Actim Gets CE Mark for SARS-CoV-2 Antibody Test
Actim said the assay has 96 percent sensitivity and 98 percent specificity and it does not cross-react with IgG antibodies against other common viruses.